Navigation Links
Virtual Colonoscopy is Most-effective for Screening Colon Cancer

A new study says targeting smaller lesions does little to significantly reduce the incidence of colorectal cancer (CRC) and, in fact, results in extremely high// financial costs and a large proportion of adverse events. A cost-benefit analysis study says the low malignancy rate among so-called diminutive polyps gives virtual colonoscopy with removal of lesions 6 mm or greater the best estimated value per life year gained and with fewer complications.

Effective screening through increased use of any of several available tests is the key to reducing deaths from colorectal cancer, the third leading cause of cancer death in both men and women. Despite the availability of effective screening tests, screening rates remain low and CRC-related deaths remain high.

Optical colonoscopy (OC) and flexible sigmoidscopy (FS) have been the primary screening tools for the last few decades but are associated with complications ¨C from abdominal pain to life-threatening bowel perforation and bleeding. Virtual colonoscopy, or CT colonography (CTC), has arisen as a potentially effective CRC screening tool. Using x-rays and imaging software to develop two- and three-dimensional images of the gastrointestinal tract, it has fewer adverse effects and is better tolerated by patients. Recent studies using new methods have demonstrated that the test is very sensitive for CRC and could be an effective screening option for patients.

Previous cost-benefit analysis studies comparing OC and CTC (with OC referral for all polyps of any size) have estimated that OC is more cost effective. However, these studies ignore current CTC guidelines that recommend only reporting polyps greater than 5 mm. Dr. Perry Pickhardt, a radiologist from the University of Wisconsin, collaborated with Dr. Cesare Hassan, a gastroenterologist from Rome, and colleagues to conduct a cost-benefit analysis comparing CTC with and without a 6-mm polyp size threshold, OC and FS.

In t his model of 100,000 persons over 50 years old, CTC with OC follow-up of polyps greater than 5 mm was the most cost-effective screening test. According to cost per life-year gained calculations, CTC with a 6-mm threshold for follow-up cost only $4,361 while OC cost $9,180 per life-year gained. CTC with no polyp size threshold cost $7,138, and FS cost $7,407 per life-year gained.

The incremental costs of working-up lesions smaller than 6 mm at CTC resulted in a significant $118,440 per additional life-year gained and accounted for more than half of all OC procedures. Moreover, working up these small, almost always benign polyps with OC caused considerable complications. The study found almost half of all OC-related complications were attributable to work-up of diminutive lesions. Furthermore, targeting these lesions did not improve screening efficacy, reducing CRC incidence by only 1.3 percent.

The authors say the data support "CTC with nonreporting of diminutive lesions" to be "the most cost-effective and safest screening option available." "Providing additional effective yet distinct screening options like CTC could encourage more adults to undergo screening," conclude the authors, and consequently "increase overall compliance with screening" for CRC.

Source-Eurekalert/M
'"/>




Related medicine news :

1. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
2. Virtual Colonoscopy May Be Better Than Real-time Colonoscopy
3. Virtual Reality For Treating Stress Disorders
4. Hip Replacement Can Now Be Performed On Virtual Patients
5. Virtual Reality Simulation Could Help In Training Surgeons
6. New Studies Show The Efficacies Of Virtual Realities Vis-à-vis Pai
7. Virtual Meeting Place Unites Patients with Brain Tumors and Neurosurgical Disorders
8. Virtual Colonoscopy in Colorectal Cancer Prevention and Screening
9. The Tech Savvy Patient Knocks on the Doors of Telemedicine and Virtual Clinics
10. Colonoscopy Could Also Identify Heart Attack Risk
11. Colonoscopy may be better to detect colon cancer in women
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2018)... ... August 15, 2018 , ... Many people might desire ... to achieve it. That’s where a great new option comes in: Injectable filler, which ... Sonoa Au, MD of Advanced Dermatology P.C. , An increasingly popular option ...
(Date:8/15/2018)... ... August 15, 2018 , ... Nowadays, it’s fairly common ... in cleansers, moisturizers and serums are known to seep into your bloodstream and accumulate ... we all become more and more informed about the quality of our skincare products, ...
(Date:8/15/2018)... ... 2018 , ... On July 30, more than 250 people attended Calvary Hospital’s ... Club in Westchester County. The event raised over $300,000 for Calvary programs and services ... included a performance by mentalist and comedian Eric Dittelman, a live auction, silent auction ...
(Date:8/14/2018)... ... August 14, 2018 , ... ... announced new leadership roles for healthcare executives Simon Frisch and Chris Weinstein, who ... respectively. They assume their roles at a time of tremendous growth for the ...
(Date:8/14/2018)... , ... August 14, 2018 , ... ... support organizations (DSO) with nearly 400 affiliated offices across 16 states, is pleased ... in San Diego, California. , Smile Brands will provide full-service administrative support to ...
Breaking Medicine News(10 mins):
(Date:8/11/2018)... ... August 10, 2018 , ... US Capital Global ... a $2 million seed funding round. Carepoynt is an emerging leader in the digital ... of a more rewarding and engaging healthcare ecosystem. , Headquartered in San Francisco, US ...
(Date:8/9/2018)... SAN LEANDRO, Calif (PRWEB) , ... August 09, 2018 , ... ... communicate and socialize with others. Given how widespread autism is, (approximately 1 in 68 ... autism cannot be “cured,” there are options to help teach a child with autism ...
(Date:8/7/2018)... ... 07, 2018 , ... Commissioner Gottlieb’s FDA:, Analysis of First Year and a ... ET, http://www.fdanews.com/commissionergottliebsfda , Under Commissioner Scott Gottlieb, changes at the FDA ... may have gotten hurt. , And Gottlieb is just getting started. , Mark the ...
Breaking Medicine Technology: